Golden
Excalibur Fund Managers

Excalibur Fund Managers

Excalibur Fund Managers is a London, England based venture capital firm focused on investments in science and human medicine companies.

Excalibur Fund Managers is a London, England based venture capital firm. They are focused solely on science and entrepreneurship in human medicines. Excalibur Fund Managers are investors, practictioners, scientists, adviser, enabler, facilitator and provider of medical and healthcare facilities.



Founded in 1996 by Sir Christopher Evans, Excalibur manages three funds, the Merlin Fund I, the Merlin Biosciences Fund, and MBF III. Across the three funds, they raised and managed a total of €450 million in 34 equity investments.



Investments

Excalibur Fund Managers has made investments in Ardana Bioscience, Neurotech, Plethora Solutions, Destination Skin, Cyclacel Pharmaceuticals, Takeda Cambridge, Intercytex Group, Onyvax, Microscience, Piramed, BioVex, Noxxon Pharma and ReNeuron Group.



They have exited their investments in ReNeuron Group, Noxxon Pharma, Cyclacel Pharmaceuticals, BioVex, Vectura, EpiCept Corporation, Arakis Limited, Energist, Plethora Solutions, Piramed and Microscience.

Timeline

Funded Companies

3 Results
Company
Company
Website
Website
Industry
Industry
Location
Location

People

Name
Role
LinkedIn

Beverley Borthwick

PA to Professor Sir Christopher Evans



Bill Edge

Board Member



Brenig Preest

Investment Director



Dr. Hellmut Krichner

Board Member



Jeremy Curnock Cook

Director



Martin Walton

Managing Director



Prof. Sir Chris Evans

Group Chairman



Professor Trevor Jones

Board Member



Shafia Zahoor

Finance Director



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References